Physician

Catherine Elizabeth Loveland-Jones, M.D.

According to 2025 Medicare claims, Catherine Loveland-Jones, M.D. (NPI: 1295996361) practices surgical oncology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is COOPER SURGICAL ASSOCIATES, PA (NPI: 1649217514; TIN: 22-2170196) and primary practice location at 08103-1461.

Loveland-Jones' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 145 traditional Medicare patients, billed 359 HCPCS/CPT codes, and received $63,836 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 38 prescription claims across 29 beneficiaries totaling $427 in drug costs, led by Lidocaine-Prilocaine (Lidocaine/Prilocaine). 2021 DME data shows 11 claims. Open Payments data shows 1 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $413 and ending at $427. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	46	111	$17,966
2016	143	399	$65,720
2017	165	451	$68,405
2018	199	466	$72,604
2019	174	393	$68,501
2020	153	345	$67,124
2021	139	318	$62,673
2022	167	323	$59,737
2023	144	353	$74,328
2024	145	359	$63,836

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	36	$413
2016	34	49	$946
2017	35	37	$233
2018	45	65	$910
2019	47	67	$448
2020	53	71	$346
2021	36	48	$487
2022	26	45	$1,066
2023	28	44	$883
2024	29	38	$427

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$956
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	34	34	$172
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	45	$125
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	21	21	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	79	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	38	46	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	285	$104

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$31	Dilon Technologies, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Catherine Elizabeth Loveland-Jones, M.D.?

Tedicare shows public-source Medicare data for Catherine Elizabeth Loveland-Jones, M.D. (NPI 1295996361), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Catherine Elizabeth Loveland-Jones, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Catherine Elizabeth Loveland-Jones, M.D.?

Catherine Elizabeth Loveland-Jones, M.D. is linked to COOPER SURGICAL ASSOCIATES, PA (billing NPI 1649217514) in the available physician profile data.

Does Catherine Elizabeth Loveland-Jones, M.D. have Open Payments data?

Catherine Elizabeth Loveland-Jones, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.